,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['destiny,breast,4', 'breast', 'astrazeneca', 'daiichi']
destiny breast-04 data reveal at #asco22 is a big win for and in her2-low breast cancer that according to some experts could change treatment practice #oncology 
https://t.co/O0ZJQGMjEP, and its digital magazine Deep Dive, is a leading online destination for healthcare and pharmaceutical industry news, insight and debate